NATICK, Mass., Sept. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22 - 25 in New York City.

Jim Tobin, Boston Scientific Chief Executive Officer, will make a 30-minute presentation which will be followed by a 30-minute question and answer session on Thursday, September 25, beginning at approximately 9:00 a.m. ET.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at http://www.bostonscientific.com/. Please visit the website for details on how to access the webcast. To ensure a timely connection to the webcast it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by UBS. The replay will be archived and available in the Investor Relations site at http://www.bostonscientific.com/ by 11:00 a.m. ET on September 25.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.

  CONTACT:  Paul Donovan
            508-650-8541 (office)
            508-667-5165 (mobile)
            Media Relations
            Boston Scientific Corporation

            Larry Neumann
            508-650-8696 (office)
            Investor Relations
            Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Media Relations, Paul Donovan, +1-508-650-8541, or cell,
+1-508-667-5165, or Investor Relations, Larry Neumann, +1-508-650-8696, both
of Boston Scientific Corporation

Web site: http://www.bostonscientific.com/